UNSPSC 51401521: Halazepam

This classification denotes a benzodiazepine with the molecular formula C17H12ClF3N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 320YC168LF, chemically known as 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2h-1,4-benzodiazepin-2-one but generally known as halazepam, which bears US NIH Compound Identifier 31640. European Medicines Agency schedules Halazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07992MIG.

UNSPSC 51401521 Halazepam is a Commodity code that appears in state and local procurement primarily as a misfiled or incidental tag within broader pharmaceutical and health-supply solicitations rather than as a driver of standalone demand. Recent opportunities tagged under this code show state and local governments procuring emergency-response medications, generic pharmaceuticals, and OTC products through competitive bidding and cooperative purchasing arrangements, but halazepam specifically does not feature prominently in the actual scope of work being solicited. State and local issuing bodies pursuing these solicitations include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, with participation extending to Oregon). The mix reflects both individual jurisdiction procurement and statewide or regional cooperative purchasing vehicles designed to aggregate demand across multiple state and local entities.

Geographic activity centers on Florida, Texas, and Minnesota with multistate cooperative reach, though the limited recent-opportunity sample does not establish a clear concentration pattern. Representative recent opportunities include Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment models; and the Minnesota Multistate Cooperative Purchasing Alliance's S1070000015802 RFP (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers. The code shows minimal recent activity aligned with halazepam procurement; the mismatch between the commodity code name and the broader pharmaceutical purchasing actually happening suggests limited relevance for halazepam-specific vendors unless broader pharmaceutical supply or emergency-response medication services are the target market.